← Back to Patent Explorer
EP0067770A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

Treatment of migraine with tropyl benzoate derivatives

Assignee: Sanofi Aventis France
•
Filing: 1982-06-11
•
Granted: —
•
Expires: 2002-06-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Migraine is treated with a tropyl benzoate derivative of the following general Formula 1:-wherein:-R, represents C<sub>1</sub>-C<sub>4</sub> alkyl, C<sub>1</sub>-C<sub>4</sub> alkoxy; or halogen;R<sub>2</sub> represents hydrogen, C<sub>1</sub>-C<sub>4</sub> alkyl, C<sub>1</sub>-C<sub>4</sub> alkoxy or halogen; andR<sub>3</sub> represents hydrogen, C<sub>1</sub>-C<sub>4</sub> alkyl, C<sub>1</sub>-C<sub>4</sub> alkoxy, or halogen provided that R<sub>3</sub> is hydrogen when R<sub>2</sub> is hydrogen.Some of the tropyl benzoate derivatives of Formula I are novel compounds.

Inventors

  • 👤 John Richard Fozard
  • 👤 Maurice Ward Gittos

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-09 21:15
CPC Classifications
C; C07; C07D; C07D451/00; C07D451/02; C07D451/04; C07D451/06; C07D451/12; A; A61; A61P; A61P25/00; A61P25/04; A61P43/00

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 111 words
A pharmaceutical composition in unit dose form for the treatment of migraine comprising, in admixture or otherwise associated with a pharmaceutically acceptable diluent or carrier, an amount of 0.5 to 100mg per unit dose of a tropyl benzoate derivative of the following general Formula I:- wherein:- R 1 represents C 1 -C 4 alkyl, C 1 -C 4 alkoxy; or halogen; R 2 represents hydrogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy or halogen; and R 3 represents hydrogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, or halogen provided that R 3 is hydrogen when R 2 is hydrogen; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 111 words
A pharmaceutical composition in unit dose form for the treatment of migraine comprising, in admixture or otherwise associated with a pharmaceutically acceptable diluent or carrier, an amount of 0.5 to 100mg per unit dose of a tropyl benzoate derivative of the following general Formula I:- wherein:- R 1 represents C 1 -C 4 alkyl, C 1 -C 4 alkoxy; or halogen; R 2 represents hydrogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy or halogen; and R 3 represents hydrogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, or halogen provided that R 3 is hydrogen when R 2 is hydrogen; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 18 words
A composition as claimed in Claim 1 containing 1 to 50 mg of said compound per unit dose.
Claim 4
Dependent Claim 18 words
A composition as claimed in Claim 2 containing 3 to 30 mg of said compound per unit dose.
Claim 5
Dependent Claim 28 words
A composition as claimed in any one of the preceding Claims wherein R 1 represents methyl, methoxy or chlorine, R 2 represents hydrogen, and R 3 represents hydrogen.
Claim 6
Dependent Claim 33 words
A composition as claimed in any one of Claims 1 to 3 wherein R 1 and R 2 are the same and each represents methyl, methoxy or chlorine, and R 3 represents hydrogen.
Claim 7
Dependent Claim 32 words
A composition as claimed in any one of Claims 1 to 3 wherein R 1 , R 2 and R 3 are all the same and each represents methyl, methoxy or chlorine.
Claim 8
Dependent Claim 28 words
A composition as claimed in any one of Claims 1 to 3 wherein the tropylbenzoate derivative is selected from tropyl-3-methoxybenzoate, tropyl-3,5-dimethoxybenzoate, tropyl-3,4,5-trimethoxybenzoate and pharmaceutically acceptable salts thereof. t
Claim 9
Dependent Claim 27 words
A composition as claimed in any one of Claims 1 to 3 wherein the tropylbenzoate derivative is selected from tropyl-3-chlorobenzoate, tropyl-3,4-dichlorobenzoate, tropyl-3,4,5-trichlorobenzoate, and pharmaceutically acceptable salts thereof.
Claim 10
Dependent Claim 28 words
A composition as claimed in any one of Claims 1 to 3 wherein the tropylbenzoate derivative is selected from tropyl- 3-methylbenzoate, tropyl-3,5-dimethylbenzoate, tropyl-3,4,5-trimethylbenzoate, and pharmaceutically acceptable salts thereof.
Claim 11
Dependent Claim 99 words
A tropyl benzoate derivative of the following general Formula I: - wherein:- R 1 represents C l -C 4 alkyl, C 1 - C 4 alkoxy; or halogen; R 2 represents hydrogen, C l -C 4 alkyl, C 1 -C 4 alkoxy or halogen; and R 3 represents hydrogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, or halogen provided that R 3 is hydrogen when R 2 is hydrogen excluding those in which R 1 , R 2 and R 3 are in a combination specified in Table I hereinbefore, or a pharmaceutically acceptable salt thereof.
Claim 12
Dependent Claim 99 words
A tropyl benzoate derivative of the following general Formula I: - wherein:- R 1 represents C l -C 4 alkyl, C 1 - C 4 alkoxy; or halogen; R 2 represents hydrogen, C l -C 4 alkyl, C 1 -C 4 alkoxy or halogen; and R 3 represents hydrogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, or halogen provided that R 3 is hydrogen when R 2 is hydrogen excluding those in which R 1 , R 2 and R 3 are in a combination specified in Table I hereinbefore, or a pharmaceutically acceptable salt thereof.
Claim 13
Dependent Claim 14 words
A compound selected from tropyl-3,5-dimethoxybenzoate, tropyl-3-methylbenzoate, tropyl-3,5-dimethylbenzoate, tropyl-3,4,5-trimethylbenzoate, tropyl-3,4,5-trichlorobenzoate and pharmaceutically acceptable salts thereof.
Claim 14
Dependent Claim 14 words
A compound selected from tropyl-3,5-dimethoxybenzoate, tropyl-3-methylbenzoate, tropyl-3,5-dimethylbenzoate, tropyl-3,4,5-trimethylbenzoate, tropyl-3,4,5-trichlorobenzoate and pharmaceutically acceptable salts thereof.
Claim 15
Dependent Claim 34 words
An analogous process for preparing a compound as claimed in Claim 10 which comprises the reaction in manner known per se of tropine and the corresponding acid halide of the following general Formula IV
Claim 16
Dependent Claim 104 words
A tropyl benzoate derivative of the following general Formula I:- wherein:- R 1 represents C 1 -C 4 alkyl, C 1 -C 4 alkoxy; or halogen; R 2 represents hydrogen, C l -C 4 alkyl, C 1 -C 4 alkoxy or halogen; and R 3 represents hydrogen, C 1 -C 4 alkyl, C1 - C4 alko xy, or halogen provided that R 3 is hydrogen when R 2 is hydrogen excluding those in which R l , R 2 and R 3 are in a combination specified in Table I hereinbefore, or a pharmaceutically acceptable salt thereof for use in the treatment of migraine.
Claim 17
Dependent Claim 104 words
A tropyl benzoate derivative of the following general Formula I:- wherein:- R 1 represents C 1 -C 4 alkyl, C 1 -C 4 alkoxy; or halogen; R 2 represents hydrogen, C l -C 4 alkyl, C 1 -C 4 alkoxy or halogen; and R 3 represents hydrogen, C 1 -C 4 alkyl, C1 - C4 alko xy, or halogen provided that R 3 is hydrogen when R 2 is hydrogen excluding those in which R l , R 2 and R 3 are in a combination specified in Table I hereinbefore, or a pharmaceutically acceptable salt thereof for use in the treatment of migraine.
Claim 18
Dependent Claim 21 words
A compound selected from tropyl-3,5-dimethoxybenzoate, tropyl-3-methylbenzoate, tropyl-3,5-dimethylbenzoate, tropyl-3,4,5-trimethylbenzoate, tropyl-3,4,5-trichlorobenzoate and pharmaceutically acceptable salts thereof for use in the treatment of migraine.
Claim 19
Dependent Claim 21 words
A compound selected from tropyl-3,5-dimethoxybenzoate, tropyl-3-methylbenzoate, tropyl-3,5-dimethylbenzoate, tropyl-3,4,5-trimethylbenzoate, tropyl-3,4,5-trichlorobenzoate and pharmaceutically acceptable salts thereof for use in the treatment of migraine.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag